Polypharmacy in Patients With Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series.
Journal Information
Full Title: J Clin Gastroenterol
Abbreviation: J Clin Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"F.M. has served as a speaker, or has received research or education funding from MSD, Abbvie, Takeda, Janssen, Pfizer, Kern Pharma, Ferring, and Dr. Falk Pharma. A.L.-S. has served as a speaker, consultant and advisory member for, or has received research funding, from MSD, AbbVie, Takeda, Pfizer, Janssen, Ferring, Shire Pharmaceuticals, Tillots, and Gebro. The remaining authors declare that they have nothing to disclose."
"This article received a grant from GETECCU (Spanish Group on Crohn’s Disease and Ulcerative Colitis) for medical writing."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025